Quantitative 68Ga-Psma-11 Pet And Outcomes In Metastatic Castration-Resistant Prostate Cancer Fol...

Quantitative 68Ga-PSMA-11 PET and Outcomes in Metastatic Castration-resistant Prostate Cancer fol...

Results Demonstrate Accuracy of the 68Ga-PSMA-11 PET for Prostate Cancer

Targeted Oncology

Dr. Fendler on Impact of 68Ga-PSMA-11 PET on Prostate Cancer Management

Dr. Hope on the Effectiveness of 68Ga-PSMA-11 PET in Prostate Cancer

Dr. Fendler on Rationale for Creating the 68Ga-PSMA-11 PET in Prostate Cancer

Dr. Hope on the Impact of Using 68Ga-PSMA-11 to Detect Pelvic Nodal Metastasis in Prostate Cancer

Relevance of 68Ga PSMA11 in prostate cancer patient management

European School of Urology

Dr. Fendler on the Utility of 68Ga-PSMA-11 PET in Prostate Cancer

Dr. Fendler on the Impact of 68Ga-PSMA-11 PET Imaging on Prostate Cancer Management

Quantitative PSMA PET/CT in the ProPSMA Study

Prostate Cancer Outcomes After Ga68-PSMA-PET Imaging

GU Oncology Now

The significant impact of PSMA-PET on prostate cancer staging and management

PSMA PET findings in 225AC-J591-treated patients with mCRPC

PSMA-Targeted Imaging in Prostate Cancer

Appropriate Use of PSMA PET in Clinical Practice

Grand Rounds in Urology

PSMA PET ratio predicts response to [177Lu]PSMA radioligand therapy: a multicenter study

Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancer

UBC Urology Rounds

Prostate Cancer, PSMA PET and Functional Imaging

University of California Television (UCTV)

Dr. Hope on Challenges With 68Ga-PSMA-11 PET in Prostate Cancer

Dr. Fendler on the Clinical Need for the 68GA-PSMA-11 PET in Prostate Cancer